Latham & Watkins LLP represented the underwriters in the offering. Cogent Biosciences, Inc. has announced the pricing of an underwritten public offering of 10,256,411 shares of…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
